PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
When Physics Fuses With Medicine: A New Therapeutic Modality for mCRPC
Visit https://www.peervoice.com/UCD860 to view the entire programme with slides. After completing “When Physics Fuses With Medicine: A New Therapeutic Modality for mCRPC”, participants will be able to: Define the clinical intent of a dual diagnostic/therapeutic radioligand strategy; Describe the rationale for targeting prostate-specific membrane antigen (PSMA) in men with metastatic castration-resistant prostate cancer (mCRPC) using a theranostic approach; Propose how the current clinical experience with emerging radioligand therapies for mCRPC informs future clinical practice.